Login / Signup

Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II.

David G BruceWendy A DavisTimothy M E Davis
Published in: Diabetes, obesity & metabolism (2018)
Tight glycaemic control may be hazardous in older people with type 2 diabetes when achieved with pharmacotherapy with metformin, and especially with insulin or sulphonylureas. These data confirm that overtreatment is likely to be an important clinical problem in this vulnerable population.
Keyphrases
  • type diabetes
  • phase ii
  • clinical trial
  • glycemic control
  • open label
  • cardiovascular disease
  • blood brain barrier
  • electronic health record
  • risk factors
  • double blind
  • placebo controlled
  • weight loss
  • study protocol